News/ News/ R&D RedHill’s oral drug boosts Veklury efficacy in severe COVID Phil Taylor RedHill 0 Comment An oral drug developed by RedHill Biopharma has reduced mortality in severe COVID-19 patients when added to therapy Share X RedHill’s oral drug boosts Veklury efficacy in severe COVID https://pharmaphorum.com/news/redhills-oral-drug-boosts-veklury-efficacy-in-severe-covid/
Podcast/ R&D/ Views & Analysis/ Views and analysis New ways to treat COVID: the pharmaphorum podcast Dominic Tyer COVID-19, Guy Goldberg, opaganib, podcast, RedHill 0 Comment In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business Share X New ways to treat COVID: the pharmaphorum podcast https://pharmaphorum.com/r-d/redhill-guy-goldberg-covid-podcast/
News/ R&D Pioneering Crohn’s antibiotic treatment meets early target Joy Persaud Crohn's disease, RedHill 0 Comment A drug targeted at treating Crohn’s disease has shown promise following positive results in a phase 3 trial. Share X Pioneering Crohn’s antibiotic treatment meets early target https://pharmaphorum.com/news/pioneering-crohns-antibiotic-treatment-meets-early-target/
